Burkhard Kerlin is currently engaged in Medical Writing Strategy & Operations at Bayer since 2024. Previously, Burkhard held the position of Head of CS/TS Medical Writing for Cardiovascular/Hematology and lead Early Authoring at Bayer from 2015 to 2019. Earlier in their career, Burkhard worked as a Clinical Project Manager at Meda from 2011 to 2014, overseeing clinical projects at ClinPharmCologne, and as a Clinical Study Manager for inVentiv Health Commercial in 2015, managing studies for Bayer Pharmaceuticals. Burkhard earned a degree from Danube University Krems between 2008 and 2011.
This person is not in the org chart
This person is not in any teams
This person is not in any offices